claim
Posted by will
•
February 19, 2026 at 09:02 AM
The insistence on high-quality data in drug approval processes protects consumers, but it can lead to unnecessary bureaucratic hurdles.
Vote to see results
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!